VANCOUVER, BC / July 25, 2018 / CVR Medical Corp. CVR Medical Corp. (CVM.V) (TSXV: CVM) (FRANKFURT: B3BN) (OTCQB: CRRVF) had entered into a letter agreement with Crystal Research Associates (“Crystal”) dated September 25, 2017 (the
Company To Explore US Capital Markets Up-Listing VANCOUVER, BC / June 7, 2018 / CVR Medical Corp. CVR Medical Corp. (CVM.V) (TSXV: CVM) (FRANKFURT: B3BN) (OTCQB: CRRVF) announces it has exclusively retained ThinkEquity, a division of Fordham
Accord Lays Pathway for Long Term Success VANCOUVER, BC / May 29 2018 / CVR Medical Corp. CVR Medical Corp. (CVM.V) (TSXV: CVM) (FRANKFURT: B3BN) (OTCQB: CRRVF) (“CVR Medical”) has reached agreement with joint venture partner CVR
VANCOUVER, BC / May 22 2018 / CVR Medical Corp. CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) (“CVR Medical”) announces it has retained BUYINS.NET, http://www.buyins.net, a leading provider of Regulation SHO compliance monitoring, short sale
VANCOUVER, BC / May 10 2018 / CVR Medical Corp. (TSX.V:CVM) (FRANKFURT: B3BN) (OTCQB: CRRVF) (“CVR Medical”) announces Colonel Dallas C. Hack, MD, MPH, MSS, FACMPH, FS, CPE has been unanimously appointed to its Board
Concludes De Novo Pathway Best Suited VANCOUVER, BC / May 9, 2018 / CVR Medical Corp. (TSX.V:CVM) (FRANKFURT: B3BN) (OTCQB: CRRVF) (“CVR Medical”) announces the receipt of official meeting minutes for their Pre-Submission meeting on March
VANCOUVER, BC / May 7, 2018 / CVR Medical Corp. (TSX.V:CVM) (FRANKFURT: B3BN) (OTCQB: CRRVF) (“CVR Medical”) is pleased to announce that Canon Virginia, Inc. (CVI) will be showcasing our Carotid Stenotic Scan (CSS) at
VANCOUVER, BC / May 1, 2018 / CVR Medical Corp. (TSX.V:CVM) (FRANKFURT: B3BN) (OTCQB: CRRVF) (“CVR Medical”) has appointed Mr. Tom J. Harris to the position of Chief Financial Officer effective May 1, 2018. As
Global Thought Leader and Entrepreneur Adds Tremendous Expertise in New Product Launches, International Expansion and Manufacturing VANCOUVER, BC / May 1, 2018 / CVR Medical Corp. (TSX.V:CVM) (FRANKFURT: B3BN) (OTCQB: CRRVF) (“CVR Medical”) is pleased
VANCOUVER, BC / April 16, 2018 / CVR Medical Corp. CVR Medical Corp. (TSX.V:CVM) (FRANKFURT: B3BN) (OTCQB: CRRVF) (“CVR Medical“) announces that it intends to complete a private placement financing for gross proceeds of up
VANCOUVER, BC / April 10, 2018 / CVR Medical Corp. CVR Medical Corp. (TSX.V:CVM) (FRANKFURT: B3BN) (OTCQB: CRRVF) (“CVR Medical”) today announced that the temporary warrant exercise price amendment expired at the close of business
VANCOUVER, BC / March 19, 2018 / CVR Medical Corp. The press release that follows is re-issued due to a typographical error in the access code of the original release (issued on March 16, 2018
CVR Medical Corp. is a med-tech organization dedicated to the development and advancement of revolutionary technology at work within the healthcare sector. Specifically, The Carotid Stenotic Scan (CSS), a groundbreaking tool which will be used to assess Carotid Arterial health in a way which is unavailable to the patient, healthcare provider, and the payor within the current system. By leveraging intellectual property, market and industry know-how, and key strategic relationships, CVR Medical has entered into a trajectory which will revolutionize healthcare and dramatically improve clinical outcomes.